Status:

COMPLETED

As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis

Lead Sponsor:

Mahidol University

Conditions:

Perennial Allergic Rhinitis

Child, Only

Eligibility:

All Genders

6-18 years

Phase:

PHASE3

Brief Summary

Allergic rhinitis in children is common. According to the international study of asthma and allergies in childhood (ISAAC) phase III, the global prevalence of allergic rhinitis among children is incre...

Detailed Description

8 week Double-blinded placebo controlled randomized controlled trial to compare the efficacy between as-needed and regular use of INCS in children with perennial allergic rhinitis.

Eligibility Criteria

Inclusion

  • Children patient (age 6 - 18 yr)
  • Mild persistent, Moderate to severe intermittent and persistent perennial allergic rhinitis
  • Rhinitis proven sensitization to aeroallergen by positive skin prick test or specific IgE result within 12 month before study recruitment
  • Mean TNSS = 4 during 7 day duration before randomization (after a washout period, discontinuation of the medications listed in exclusion criteria

Exclusion

  • Patients with rhinosinusitis, nasal polyps, or significant deviated nasal septum
  • Patients with a history of uncontrolled asthma, chronic lung disease, cardiovascular, hepatic, or renal diseases
  • Patients taking oral or nasal decongestants within 7 d
  • Patients taking INCS within 4 week
  • Patients taking systemic corticosteroid within 8 week
  • Patients taking H1 antihistamine within 1 week
  • Patients taking antileukotriene within 4 week
  • Patients who were currently or previously treated with allergen immunotherapy
  • Patients with a history of upper respiratory tract infection within 14 d
  • Patients with primary and secondary immune deficiency

Key Trial Info

Start Date :

April 4 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2025

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT05299086

Start Date

April 4 2022

End Date

April 30 2025

Last Update

November 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, Bangkok, Thailand, 10700

As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis | DecenTrialz